Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04464200
What this trial is testing

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Who this might be right for
Diffuse Large B Cell LymphomaPrimary Mediastinal Large B Cell LymphomaTransformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma+6 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003245
What this trial is testing

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05842707
What this trial is testing

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Who this might be right for
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Aibin Liang，MD，Ph.D. 48
Large-scale testing (Phase 3)Active Not RecruitingNCT04442022
What this trial is testing

Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics Inc 501
Testing effectiveness (Phase 2)Looking for participantsNCT05702853
What this trial is testing

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Who this might be right for
B-cell Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Medical University of South Carolina 27
Testing effectiveness (Phase 2)WithdrawnNCT04607772
What this trial is testing

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Karyopharm Therapeutics Inc
Early research (Phase 1)UnknownNCT05020639
What this trial is testing

TQB3820 in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 116
Testing effectiveness (Phase 2)Study completedNCT02342665
What this trial is testing

Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL

Who this might be right for
Lymphoma Non-Hodgkin
Bayer 25
Testing effectiveness (Phase 2)Ended earlyNCT00383565
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 9
Early research (Phase 1)Active Not RecruitingNCT06079164
What this trial is testing

Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma

Who this might be right for
Relapsed/Refractory Large B-cell Lymphoma
Kite, A Gilead Company 21
Early research (Phase 1)Study completedNCT05233033
What this trial is testing

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell LymphomaDLBCL+1 more
Kymera Therapeutics, Inc. 7
Early research (Phase 1)Study completedNCT02175433
What this trial is testing

Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

Who this might be right for
Relapsed Lymphoid MalignancyRefractory Lymphoid Malignancy
Astellas Pharma Global Development, Inc. 71
Early research (Phase 1)Study completedNCT04313608
What this trial is testing

A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 23
Early research (Phase 1)Study completedNCT01991184
What this trial is testing

GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
Genentech, Inc. 24
Very early researchStudy completedNCT04689204
What this trial is testing

CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
He Huang 3
Testing effectiveness (Phase 2)Study completedNCT00059904
What this trial is testing

Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05535673
What this trial is testing

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Who this might be right for
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL
Zhengzhou University 15
Testing effectiveness (Phase 2)Study completedNCT01499303
What this trial is testing

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

Who this might be right for
Diffuse Large B-Cell Lymphoma
AstraZeneca 101
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00136591
What this trial is testing

Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma

Who this might be right for
Follicular Lymphoma
Lymphoma Study Association 87
Next Page